Regulatory Perspective of Complementary Medicines in Australia

The webinar was successfully concluded on

Aug 26, 2021. 

We are elated to see your interest in Freyr’s Webinar Series (FWS). The webinar on, ‘Regulatory Perspective of Complementary Medicines in Australia’ was successfully concluded on Aug 26, 2021. Here is an archived version for your kind perusal.

What Was It All About?

In brief, during the webinar our in-house Regulatory experts – Kamalakar Deevi and Malgorzata Wojciechowska shared their inputs thoroughly on:

  • Complementary Medicines Regulatory Structure in Australia
  • Launch of Complementary Medicines Through Listing (L-process) or Registration (R- process)
  • Good Manufacturing Practices (GMP) Requirements for Complementary Medicines
  • Permissible Ingredients and TGA Assessed Claims
  • Information for Sponsors to Market Complementary Medicines in Australia

As a continuous practice, Freyr intends to conduct more informative webinar sessions related to Regulatory aspects of Life Sciences. We presume that you would like to be a part of all our upcoming sessions. If yes, let us have an opportunity to inform you about our next session.